ClinicalTrials.gg
Sign In

Rosacea clinical trials

The registry lists 233 studies for Rosacea across more than 10 countries. 23 are recruiting or about to start. 205 of them are mainly about Rosacea (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Rosacea studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
175
Recruiting
17
Status unknown
16
Withdrawn
9
Terminated
8
Enrolling by invitation
3

Phase

Phase 2
58
Phase 3
43
Phase 1
28
Phase 4
27
Early Phase 1
4

Where

United States
145
Canada
17
China
16
Germany
14
France
11
Sweden
6

Who runs them

Galderma R&D (25) · LEO Pharma (8) · Allergan (7) · Vyne Therapeutics Inc. (5) · Actavis Inc. (5) · Sol-Gel Technologies, Ltd. (5) · Maruho Co., Ltd. (5) · Padagis LLC (4)

What is being tested here

Drugs under test in Rosacea studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Minocycline105
Metronidazole114
Botulinum toxin type A103
Lotilaner101
Tranilast101
Remibrutinib101
Tofacitinib101
Imipramine101
Amitriptyline101
Clascoterone101

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 2 open

Coming up

0phase 3 studies under way
9studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 9

Who these studies take

Of the 17 Rosacea studies recruiting now, 9 (53%) set no upper age limit and 7 (41%) stop at 75 or younger. 1 (6%) take children under 18. 2 (12%) are for women only and 0 (0%) for men only; 8 (47%) take healthy volunteers.

Recruiting studies that take each age, of 17
AgeWomenMen
101 (6%)1 (6%)
1814 (82%)14 (82%)
3016 (94%)15 (88%)
4017 (100%)15 (88%)
5017 (100%)15 (88%)
6513 (76%)13 (76%)
7510 (59%)10 (59%)
859 (53%)9 (53%)

Across all 233 studies, recruiting or not: 33% stop at 75 or younger and 24% at 65; 4% take children; 4% are for women only and <1% for men only; 25% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Rosacea studies take

Of 20 phase 2 interventional studies under Rosacea, half reached primary completion within 12 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 18 mo5–13 · 13 studies——
Phase 212 mo7–16 · 20 studies——
Phase 311 mo9–15 · 17 studies——
Phase 413 mo6–21 · 12 studies——
Interventional, no phase13 mo7–29 · 42 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Results posted1

Stopped1

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 233. Browse all 233 → or search them.